guanidine and etoposide

guanidine has been researched along with etoposide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Titulaer, MJ; van Gerven, J; Verschuuren, JJ; Willems, LN; Wirtz, PW1
Chakraborty, A; De, A; Patravale, V; Pawar, Y; Sable, S; Selkar, N; Shete, H; Tidke, P; Vanage, G1

Reviews

2 review(s) available for guanidine and etoposide

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Available treatment options for the management of Lambert-Eaton myasthenic syndrome.
    Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:10

    Topics: 4-Aminopyridine; Antineoplastic Agents; Carcinoma, Small Cell; Cholinesterase Inhibitors; Cisplatin; Etoposide; Guanidine; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Parasympathomimetics; Plasmapheresis; Potassium Channel Blockers; Prednisolone; Pyridostigmine Bromide; Randomized Controlled Trials as Topic

2006

Other Studies

1 other study(ies) available for guanidine and etoposide

ArticleYear
Mono-guanidine heterolipid based SMEDDS: A promising tool for cytosolic delivery of antineoplastics.
    Biomaterials, 2015, Volume: 57

    Topics: Animals; Antineoplastic Agents; Biological Availability; Cell Line, Tumor; Cell Proliferation; Drug Carriers; Drug Delivery Systems; Emulsions; Etoposide; Female; Guanidine; Lipids; Melanoma; Mice, Inbred C57BL; Solubility

2015